COMMUNIQUÉS West-GlobeNewswire

SAFE - COMPTE-RENDU DE L’ASSEMBLEE GENERALE EXTRAORDINAIRE DU 26 JUILLET 2024

29/07/2024 - 18:15

COMPTE-RENDU DE L’ASSEMBLEE GENERALE EXTRAORDINAIRE DU 26 JUILLET 2024 Fleurieux-sur-l’Arbresle - France - le 29 juillet 2024 à 18h15 . L’Assemblée Générale Extraordinaire des actionnaires de Safe (FR001400F1V2 – ALSAF [...]

SAFE - FIRST-HALF 2024 SALES

29/07/2024 - 18:00

FIRST-HALF 2024 SALES Fleurieux-sur-l’Arbresle - France - July 29, 2024, 6.00 p.m. The group Safe (FR001400F1V2 – ALSAF) announces consolidated sales for 1st half 2024. In k€ First-half 2024* First-half 2023 % change [...]

SAFE - CHIFFRE D’AFFAIRES DU 1ER SEMESTRE 2024

29/07/2024 - 18:00

CHIFFRE D’AFFAIRES DU 1 ER SEMESTRE 2024 Fleurieux-sur-l’Arbresle - France - le 29 juillet 2024 à 18h . Safe (FR001400F1V2 – ALSAF) annonce son chiffre d’affaires consolidé sur le 1 er semestre 2024. En k€ S1 2024* S1 [...]

Orchid Launches the First HIPAA-Compliant AI-Powered Clinical Notes Solution for Mental Health Clinicians - Integrates With Any EHR To Help Automate Note Taking and Free Up Time for Patient Care

29/07/2024 - 17:25

Orchid’s AI reduces clinical note writing from 20 minutes down to a few seconds per session WILMINGTON, Del., July 29, 2024 (GLOBE NEWSWIRE) -- Orchid , the first and only AI-powered EHR for mental health, announced [...]

Zealand Pharma Appoints Eric Cox as Chief Commercial Officer

29/07/2024 - 17:00

Press release – 7 / 2024 Zealand Pharma Appoints Eric Cox as Chief Commercial Officer Copenhagen, Denmark, 29 July 2024 – Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) (CVR-no. 20045078), a biotechnology company focused [...]

Vave Health and Inteleos Foundation Announce Partnership to Expand Global Access to Ultrasound Technology

29/07/2024 - 16:56

SAN JOSE, Calif. and ROCKVILLE, Md., July 29, 2024 (GLOBE NEWSWIRE) -- Vave Health, an innovative ultrasound device manufacturer, and the Inteleos Foundation, a global non-profit organization dedicated to driving equity [...]

AAMI Releases Alternative Guidance for Radiation Sterilization

29/07/2024 - 16:45

Arlington, Virginia, July 29, 2024 (GLOBE NEWSWIRE) -- Right now, pharmaceutical and biopharmaceutical manufacturers often rely on outdated best practices related to radiation sterilization and routine control of single [...]

BioPorto to Debut FDA Approved ProNephro AKI at Upcoming ADLM 2024 Clinical Lab Expo

29/07/2024 - 16:35

July 29, 2024 News Release BioPorto to Debut FDA Approved ProNephro AKI at Upcoming ADLM 2024 Clinical Lab Expo ADLM 2024 Conference – Chicago, July 29, 2024 – BioPorto Diagnostics, a company specializing in in vitro [...]

Product Manager Scott Myers to Present at 2nd Global Summit on Artificial Intelligence

29/07/2024 - 15:55

AGOURA HILLS, Calif., July 29, 2024 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) ("Oncotelic", the "Company" or "We" or “Our”), announced today that Product Manager Scott Myers, working through GMP [...]

Wake Radiology Adds Rad AI Technology to Revolutionize Radiology Reporting

29/07/2024 - 15:30

Powerful generative AI software will enhance diagnostic speed, precision & patient outcomes Raleigh, July 29, 2024 (GLOBE NEWSWIRE) -- Wake Radiology UNC REX Healthcare, a leading provider of outpatient medical [...]

AIM ImmunoTech Announces Release of the Next CEO Corner Segment

29/07/2024 - 15:15

OCALA, Fla., July 29, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced the next CEO Corner segment has been published on the Company’s website. In the CEO [...]

Hapbee Announces Closing of Non-Brokered Private Placement

29/07/2024 - 15:15

VANCOUVER, British Columbia, July 29, 2024 (GLOBE NEWSWIRE) -- Hapbee Technologies, Inc. (the “ Company ” or “ Hapbee ”) (TSX-V: HAPB) (OTCQB: HAPBF) (FSE: HA1) – The Company is pleased to announce that it has now [...]

Spectral AI Schedules 2024 Second Quarter Financial Results and Conference Call

29/07/2024 - 15:00

DALLAS, July 29, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”) , an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment [...]

INmune Bio Inc. Announces New Phase 1 Study Data Demonstrating Dose-Dependent Effect of XPro™ on Proteins that Regulation Synapses in Alzheimer’s Patients

29/07/2024 - 15:00

AAIC Poster Presentation Highlights XPro's™ Significant Effects on a Wide Range of Synaptic Proteins and Pathways BOCA RATON, Fla., July 29, 2024 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a [...]

Promex Industries and QP Technologies Implement Sales/Marketing Reorganization, Promoting Rosie Medina to Promex Senior Vice President and Matt Hansen to QP Technologies Vice President

29/07/2024 - 15:00

Two companies heightening focus on individual core competencies to better pursue rapidly expanding business opportunities SANTA CLARA, Calif., July 29, 2024 (GLOBE NEWSWIRE) -- Promex Industries , a Silicon Valley-based [...]

Calidi Biotherapeutics Announces Launch of Nova Cell Subsidiary and $3 Million Aggregate Investment from Dr. Ronald Rigor

29/07/2024 - 15:00

SAN DIEGO, July 29, 2024 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI or “Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, [...]

Longeveron® Presents Study Results from CLEAR MIND Phase 2a Clinical Trial of Lomecel-B™ in Mild Alzheimer’s Disease at the Alzheimer’s Association International Conference® (AAIC)

28/07/2024 - 22:51

– Featured Research Session oral presentation highlights findings that show Lomecel-B™ improved cognitive function, quality of life, and brain volume in the treatment of mild Alzheimer’s Disease – – Study meets its key [...]

Regeneration Biomedical to Present Data on First Two Subjects in a Phase I Clinical Trial of Stem Cell Therapy delivered directly into the brains of Patients with Alzheimer’s Disease

28/07/2024 - 14:05

Wnt-activated, autologous, expanded, adipose-derived stem cells administered directly into lateral ventricles of the brain via Ommaya reservoir implanted under the scalp to bypass blood brain barrier Data to be [...]

Acumen Pharmaceuticals Presents Patient Experience and Biomarker Data from Phase 1 INTERCEPT-AD Study at the Alzheimer’s Association International Conference (AAIC®) 2024

28/07/2024 - 13:30

NEWTON, Mass., July 28, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers ( [...]